These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31570178)

  • 1. Age dependency of mGluR5 availability in 5xFAD mice measured by PET.
    Lee M; Lee HJ; Jeong YJ; Oh SJ; Kang KJ; Han SJ; Nam KR; Lee YJ; Lee KC; Ryu YH; Hyun IY; Choi JY
    Neurobiol Aging; 2019 Dec; 84():208-216. PubMed ID: 31570178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aβ pathology downregulates brain mGluR5 density in a mouse model of Alzheimer.
    Lee M; Lee HJ; Park IS; Park JA; Kwon YJ; Ryu YH; Kim CH; Kang JH; Hyun IY; Lee KC; Choi JY
    Neuropharmacology; 2018 May; 133():512-517. PubMed ID: 29427650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [
    Fang XT; Eriksson J; Antoni G; Yngve U; Cato L; Lannfelt L; Sehlin D; Syvänen S
    Neuropharmacology; 2017 Feb; 113(Pt A):293-300. PubMed ID: 27743932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mGluR5/PI3K-AKT Pathway Alleviates Alzheimer's Disease-Like Pathology Through the Activation of Autophagy in 5XFAD Mice.
    Chen Y; Zhang Y; Chen Q; Liu Y; Wei X; Wu M; Zhang K; Liu Y; Wei W
    J Alzheimers Dis; 2023; 91(3):1197-1214. PubMed ID: 36565127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment.
    Wang J; Huang Q; He K; Li J; Guo T; Yang Y; Lin Z; Li S; Vanderlinden G; Huang Y; Van Laere K; Guan Y; Guo Q; Ni R; Li B; Xie F
    Alzheimers Dement; 2024 Jun; 20(6):3876-3888. PubMed ID: 38634334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer's disease: A [
    Wang J; He Y; Chen X; Huang L; Li J; You Z; Huang Q; Ren S; He K; Schibli R; Mu L; Guan Y; Guo Q; Zhao J; Xie F
    Alzheimers Res Ther; 2024 Jan; 16(1):9. PubMed ID: 38217040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging of mGluR5 in Alzheimer's disease.
    Mecca AP; McDonald JW; Michalak HR; Godek TA; Harris JE; Pugh EA; Kemp EC; Chen MK; Salardini A; Nabulsi NB; Lim K; Huang Y; Carson RE; Strittmatter SM; van Dyck CH
    Alzheimers Res Ther; 2020 Jan; 12(1):15. PubMed ID: 31954399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography.
    Rojas S; Herance JR; Gispert JD; Abad S; Torrent E; Jiménez X; Pareto D; Perpiña U; Sarroca S; Rodríguez E; Ortega-Aznar A; Sanfeliu C
    Neurobiol Aging; 2013 Jul; 34(7):1790-8. PubMed ID: 23402900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Characterization of mGluR5 Using
    Bertoglio D; Kosten L; Verhaeghe J; Thomae D; Wyffels L; Stroobants S; Wityak J; Dominguez C; Mrzljak L; Staelens S
    J Nucl Med; 2018 Nov; 59(11):1722-1727. PubMed ID: 29794227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients.
    Müller Herde A; Schibli R; Weber M; Ametamey SM
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):407-420. PubMed ID: 30291374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease.
    Abd-Elrahman KS; Ferguson SSG
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():235-254. PubMed ID: 34516293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer's Mouse Phenotypes.
    Haas LT; Salazar SV; Smith LM; Zhao HR; Cox TO; Herber CS; Degnan AP; Balakrishnan A; Macor JE; Albright CF; Strittmatter SM
    Cell Rep; 2017 Jul; 20(1):76-88. PubMed ID: 28683325
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Franke TN; Irwin C; Bayer TA; Brenner W; Beindorff N; Bouter C; Bouter Y
    Front Med (Lausanne); 2020; 7():529. PubMed ID: 33043029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
    Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
    Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Detection of A
    Oh SJ; Lee HJ; Kang KJ; Han SJ; Lee YJ; Lee KC; Lim SM; Chi DY; Kim KM; Park JA; Choi JY
    Contrast Media Mol Imaging; 2018; 2018():5272014. PubMed ID: 29681782
    [No Abstract]   [Full Text] [Related]  

  • 17. Excitotoxic neurodegeneration is associated with a focal decrease in metabotropic glutamate receptor type 5 availability: an in vivo PET imaging study.
    Crabbé M; Dirkx N; Casteels C; Laere KV
    Sci Rep; 2019 Sep; 9(1):12916. PubMed ID: 31501497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term RF exposure on behavior and cerebral glucose metabolism in 5xFAD mice.
    Son Y; Kim JS; Jeong YJ; Jeong YK; Kwon JH; Choi HD; Pack JK; Kim N; Lee YS; Lee HJ
    Neurosci Lett; 2018 Feb; 666():64-69. PubMed ID: 29273398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral dopaminergic and glutamatergic transmission relate to different subjective responses of acute alcohol intake: an in vivo multimodal imaging study.
    Leurquin-Sterk G; Ceccarini J; Crunelle CL; Weerasekera A; de Laat B; Himmelreich U; Bormans G; Van Laere K
    Addict Biol; 2018 May; 23(3):931-944. PubMed ID: 28884874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.